Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 01/05/24 07:00:00 on US and Canada Markets.
– Median Progression-Free Survival for QINLOCK ® of 14.2 Months Versus 1.5 Months for Sunitinib – – Objective Response Rate of 44.4% for QINLOCK Versus 0% for Sunitinib – – Median Overall Survival for QINLOCK was Not Estimable Versus 1...
BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT PR Newswire MINNEAPOLIS , Jan. 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President,...
Partnership focused on utilizing Axiomer ™ to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndrome Collaboration expands ProQR’s commitment to advance the development of therapies for central nervous system diseases LEIDEN,...
Fiscal Year 2024 Second Quarter Highlights Net sales of $79.1 million increased 2.7% on a pro-forma basis compared to the prior-year quarter Med Tech net sales of $25.4 million increased 3.5% Med Device net sales of $53.7 million increased 2.3% on a pro-forma basis ...
Exceptional brand strategist and merchant tapped to lead the buying and merchandising team for the iconic teen footwear retailer Genesco Inc. (NYSE: GCO) announced today the appointment of Chris Santaella as executive vice president and chief merchandising officer of the Journeys Group,...
RAPIDe-3, a global Phase 3 clinical study of deucrictibant for the on-demand treatment of HAE, to initiate within 1H24 Results of nonclinical rodent toxicology study submitted to the FDA Jochen Knolle, Ph.D., to transition to strategic advisor to the CEO and Executive Committee Comp...
Enrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIA Confirmed with FDA that a single pivotal efficacy trial with L606 will support PAH and PH-ILD indications MORRISVILLE, N.C., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Co...
Global Phase 3 studies started for bomedemstat (LSD1 inhibitor), nemtabrutinib (BTK inhibitor), MK-2870 (anti-TROP2 ADC) and MK-5684 (CYP11A1 inhibitor) Comprehensive clinical development programs being initiated for each investigational candidate Demonstrates company's commitment...
Medtronic receives CE Mark for its next generation Micra leadless pacing systems PR Newswire New pacemakers offer 40% more battery life, 1 extend Medtronic legacy of pacing leadership DUBLIN , Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a ...
Kinsale Capital Group, Inc. (NYSE: KNSL) (the “Company”) announced today changes to its Board of Directors (the “Board”) and management structure effective March 1, 2024. Michael P. Kehoe has been appointed Chairman of the Board in addition to his role as Chief Executi...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-1.89%Change Percent:
Loop Media Inc Company Name:
LPTV Stock Symbol:
OTCMKTS Market: